|
1
|
Chabaud M, Durand JM, Buchs N, et al:
Human interleukin-17: A T cell-derived proinflammatory cytokine
produced by the rheumatoid synovium. Arthritis Rheum. 42:963–970.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Miossec P: Interleukin-17 in fashion, at
last: ten years after its description, its cellular source has been
identified. Arthritis Rheum. 56:2111–2115. 2007.PubMed/NCBI
|
|
3
|
Van Boxel JA and Paget SA: Predominantly
T-cell infiltrate in rheumatoid synovial membranes. N Engl J Med.
293:517–520. 1975.PubMed/NCBI
|
|
4
|
Hovdenes J, Gaudernack G, Kvien TK, et al:
A functional study of purified CD4+ and CD8+
cells isolated from synovial fluid of patients with rheumatoid
arthritis and other arthritides. Scand J Immunol. 29:641–649.
1989.PubMed/NCBI
|
|
5
|
Imboden JB: The immunopathogenesis of
rheumatoid arthritis. Annu Rev Pathol. 4:417–434. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Courtenay JS, Dallman MJ, Dayan AD, et al:
Immunisation against heterologous type II collagen induces
arthritis in mice. Nature. 283:666–668. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Holmdahl R, Rubin K, Klareskog L, et al:
Characterization of the antibody response in mice with type II
collagen-induced arthritis, using monoclonal anti-type II collagen
antibodies. Arthritis Rheum. 29:400–410. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Keystone EC, Schorlemmer HU, Pope C and
Allison AC: Zymosan-induced arthritis: a model of chronic
proliferative arthritis following activation of the alternative
pathway of complement. Arthritis Rheum. 20:1396–1401.
1977.PubMed/NCBI
|
|
9
|
Sakaguchi N, Takahashi T, Hata H, et al:
Altered thymic T-cell selection due to a mutation of the ZAP-70
gene causes autoimmune arthritis in mice. Nature. 426:454–460.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Andersson M, Cremer MA, Terato K, et al:
Analysis of type II collagen reactive T cells in the mouse. II
Different localization of immunodominant T cell epitopes on
heterologous and autologous type II collagen. Scand J Immunol.
33:505–510. 1991.PubMed/NCBI
|
|
11
|
Andersson M and Holmdahl R: Analysis of
type II collagen-reactive T cells in the mouse. I Different
regulation of autoreactive vs non-autoreactive anti-type II
collagen T cells in the DBA/1 mouse. Euro J Immunol. 20:1061–1066.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Iwai H, Kozono Y, Hirose S, et al:
Amelioration of collagen-induced arthritis by blockade of inducible
costimulator-B7 homologous protein costimulation. J Immunol.
169:4332–4339. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Deng GM, Zheng L, Chan FK and Lenardo M:
Amelioration of inflammatory arthritis by targeting the pre-ligand
assembly domain of tumor necrosis factor receptors. Nat Med.
11:1066–1072. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Su Z, Sun C, Zhou C, Liu Y, et al: HMGB1
blockade attenuates experimental autoimmune myocarditis and
suppresses Th17-cell expansion. Eur J Immunol. 41:3586–3595. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Brand DD, Latham KA and Rosloniec EF:
Collagen-induced arthritis. Nat Protoc. 2:1269–1275. 2007.
View Article : Google Scholar
|
|
16
|
Korn T, Bettelli E, Oukka M and Kuchroo
VK: IL-17 and Th17 cells. Annu Rev Immunol. 27:485–517. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lane P, Kim MY, Withers D, et al: Lymphoid
tissue inducer cells in adaptive CD4 T cell dependent responses.
Semin Immunol. 20:159–163. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lane PJ, McConnell FM, Withers D, et al:
Lymphoid tissue inducer cells: bridges between the ancient innate
and the modern adaptive immune systems. Mucosal Immunol. 2:472–477.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Takatori H, Kanno Y, Watford WT, et al:
Lymphoid tissue inducer-like cells are an innate source of IL-17
and IL-22. J Exp Med. 206:35–41. 2009.PubMed/NCBI
|
|
20
|
Alzabin S and Williams RO: Effector T
cells in rheumatoid arthritis: lessons from animal models. FEBS
Lett. 585:3649–3659. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kageyama Y, Ichikawa T, Nagafusa T, et al:
Etanercept reduces the serum levels of interleukin-23 and
macrophage inflammatory protein-3 alpha in patients with rheumatoid
arthritis. Rheumatol Int. 28:137–143. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sarkar S, Cooney LA, White P, et al:
Regulation of pathogenic IL-17 responses in collagen-induced
arthritis: roles of endogenous interferon-gamma and IL-4. Arthritis
Res Ther. 11:R1582009. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Doodes PD, Cao Y, Hamel KM, et al:
IFN-gamma regulates the requirement for IL-17 in
proteoglycan-induced arthritis. J Immunol. 184:1552–1559. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhu J and Paul WE: CD4 T cells: fates,
functions and faults. Blood. 112:1557–1569. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Locksley RM: Nine lives: plasticity among
T helper cell subsets. J Exp Med. 206:1643–1646. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Peck A and Mellins ED: Plasticity of
T-cell phenotype and function: the T helper type 17 example.
Immunology. 129:147–153. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yamada H, Nakashima Y, Okazaki K, et al:
Th1 but not Th17 cells predominate in the joints of patients with
rheumatoid arthritis. Ann Rheum Dis. 67:1299–1304. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kato H and Fox DA: Are Th17 cells an
appropriate new target in the treatment of rheumatoid arthritis?
Clin Transl Sci. 3:319–326. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Selmi C: Autoimmunity in 2009. Autoimmun
Rev. 9:795–800. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Scheinecker C and Smolen JS: Rheumatoid
arthritis in 2010: from the gut to the joint. Nat Rev Rheumatol.
7:73–75. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lubberts E, Koenders MI, Oppers-Walgreen
B, et al: Treatment with a neutralizing anti-murine interleukin-17
antibody after the onset of collagen-induced arthritis reduces
joint inflammation, cartilage destruction and bone erosion.
Arthritis Rheum. 50:650–659. 2004. View Article : Google Scholar
|
|
32
|
Nakae S, Nambu A, Sudo K and Iwakura Y:
Suppression of immune induction of collagen-induced arthritis in
IL-17-deficient mice. J Immunol. 171:6173–6177. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Arnett FC, Edworthy SM, Bloch DA, et al:
The American Rheumatism Association 1987 revised criteria for the
classification of rheumatoid arthritis. Arthritis Rheum.
31:315–324. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Corr M and Firestein GS: Innate immunity
as a hired gun: but is it rheumatoid arthritis? J Exp Med.
195:F33–F35. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Falgarone G, Jaen O and Boissier MC: Role
for innate immunity in rheumatoid arthritis. Joint Bone Spine.
72:17–25. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Maciejewska Rodrigues H, Jungel A, Gay RE
and Gay S: Innate immunity, epigenetics and autoimmunity in
rheumatoid arthritis. Mol Immunol. 47:12–18. 2009.PubMed/NCBI
|
